Bpifrance SA Long-Term Concentrated

CIK: 0001731118 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Jul 31, 2020

Total Value ($000): $405,438 (100.0% shares, 0.0% debt)

Holdings (7)

FTI TECHNIPFMC PLC 41.8%

Value ($000) $169,362 Shares 24,688,691 Est. Cost $17.41 Unrealized -67.1%

— CONSTELLIUM NV 31.1%

Value ($000) $125,905 Shares 16,393,903 Est. Cost $6.99 Unrealized —

— TALEND S A 13.8%

Value ($000) $55,903 Shares 1,612,895 Est. Cost $37.08 Unrealized —

CRTO CRITEO S A 7.6%

Value ($000) $30,967 Shares 2,718,752 Est. Cost $22.72 Unrealized —

— SEQUANS COMMUNICATIONS S A 5.2%

Value ($000) $21,185 Shares 3,450,259 Est. Cost $1.45 Unrealized —

— MILLENDO THERAPEUTICS INC 0.5%

Value ($000) $1,898 Shares 1,078,670 Est. Cost $7.95 Unrealized —

CRNX CRINETICS PHARMACEUTICALS 0.1%

Value ($000) $218 Shares 12,418 Est. Cost $17.05 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
FTI	TECHNIPFMC PLC	24,688,691	$169,362	41.8%	$17.41	-67.1%	COM	G87110105
—	CONSTELLIUM NV	16,393,903	$125,905	31.1%	$6.99	—	CL A	N22035104
—	TALEND S A	1,612,895	$55,903	13.8%	$37.08	—	ADS	874224207
CRTO	CRITEO S A	2,718,752	$30,967	7.6%	$22.72	—	SPONS ADS	226718104
—	SEQUANS COMMUNICATIONS S A	3,450,259	$21,185	5.2%	$1.45	—	SPONS ADS	817323108
—	MILLENDO THERAPEUTICS INC	1,078,670	$1,898	0.5%	$7.95	—	COM	60040X103
CRNX	CRINETICS PHARMACEUTICALS	12,418	$218	0.1%	$17.05	0.0%	COM	22663K107